These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26883008)

  • 1. MicroRNA-365a-3p promotes tumor growth and metastasis in laryngeal squamous cell carcinoma.
    Geng J; Liu Y; Jin Y; Tai J; Zhang J; Xiao X; Chu P; Yu Y; Wang SC; Lu J; Han S; Shi J; Guo Y; Ni X
    Oncol Rep; 2016 Apr; 35(4):2017-26. PubMed ID: 26883008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma.
    Li JZ; Gao W; Lei WB; Zhao J; Chan JY; Wei WI; Ho WK; Wong TS
    Oncotarget; 2016 Sep; 7(36):58218-58233. PubMed ID: 27533461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA PVT1 promotes laryngeal squamous cell carcinoma development by acting as a molecular sponge to regulate miR-519d-3p.
    Zheng X; Zhao K; Liu T; Liu L; Zhou C; Xu M
    J Cell Biochem; 2019 Mar; 120(3):3911-3921. PubMed ID: 30304557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
    Jili S; Eryong L; Lijuan L; Chao Z
    Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-330-3p represses the proliferation and invasion of laryngeal squamous cell carcinoma through downregulation of Tra2β-mediated Akt signaling.
    Cheng Y; Zhu H; Gao W
    Mol Cell Probes; 2020 Aug; 52():101574. PubMed ID: 32289378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circ_0023028 contributes to the progression of laryngeal squamous cell carcinoma by upregulating LASP1 through miR-486-3p.
    Zheng Y; Duan L; Yang Y; Luo D; Yan B
    Mol Cell Biochem; 2021 Aug; 476(8):2951-2961. PubMed ID: 33755879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-144-3p, a tumor suppressive microRNA targeting ETS-1 in laryngeal squamous cell carcinoma.
    Zhang SY; Lu ZM; Lin YF; Chen LS; Luo XN; Song XH; Chen SH; Wu YL
    Oncotarget; 2016 Mar; 7(10):11637-50. PubMed ID: 26826553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of laryngeal squamous cell cancer progression by the lncRNA H19/miR-148a-3p/DNMT1 axis.
    Wu T; Qu L; He G; Tian L; Li L; Zhou H; Jin Q; Ren J; Wang Y; Wang J; Kan X; Liu M; Shen J; Guo M; Sun Y
    Oncotarget; 2016 Mar; 7(10):11553-66. PubMed ID: 26872375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NEAT1 promotes proliferation, migration, and invasion of laryngeal squamous cell carcinoma cells through miR-411-3p/FZD3-mediated Wnt signaling pathway.
    Liang J; Fang F; Gao X; Shi J; Zhao J; Zhao Y
    BMC Cancer; 2024 Jul; 24(1):904. PubMed ID: 39068410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis.
    Wang Z; Huang C; Zhang A; Lu C; Liu L
    Biomed Pharmacother; 2020 May; 125():109874. PubMed ID: 32014687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.
    Kang Z; Zhang C; Huangfu H
    Biochem Genet; 2024 Jun; 62(3):2117-2133. PubMed ID: 37863866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of MiR-206 promotes proliferation and invasion of laryngeal cancer by regulating VEGF expression.
    Zhang T; Liu M; Wang C; Lin C; Sun Y; Jin D
    Anticancer Res; 2011 Nov; 31(11):3859-63. PubMed ID: 22110210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
    Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
    Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT.
    Wang B; Lv K; Chen W; Zhao J; Luo J; Wu J; Li Z; Qin H; Wong TS; Yang W; Fu QL; Lei W
    Biomed Res Int; 2016; 2016():9652789. PubMed ID: 28078305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-365a-3p suppresses proliferation and invasion of Hep-2 cells through targeting ten-eleven translocation 1 (TET1).
    Li J; Shen N; Bai GP; Huang XS
    Neoplasma; 2018 Sep; 65(5):730-735. PubMed ID: 30249104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA‑195 is associated with regulating the pathophysiologic process of human laryngeal squamous cell carcinoma.
    Pang H; Xu X; Dai L; Wang K; Yao X
    Mol Med Rep; 2018 Apr; 17(4):5283-5291. PubMed ID: 29393451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.